2026612
PR Heartseed, World's First Clinical Trial of Catheter Administration of iPSC-Derived Cardiomyocyte Spheroids: First Patient Dosed
202668
Congress Keiichi Fukuda, CEO, to Speak at the 10th Cardiovascular Bioengineering (CVBE) Symposium 2026
2026216
PR Notice Regarding Selection as a Constituent of the JPX Start-Up Acceleration 100 Index
202629
Seminar Keiichi Fukuda, CEO, to Speak at The 21st Edition of Roundtable Japan
2026119
Congress Keiichi Fukuda, CEO, to Speak at Keystone Symposia "iPSCs: Progress, Opportunities, and Challenges"
